首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Dispersive liquid-liquid microextraction based on solidification of floating organic droplets followed by high performance liquid chromatography for the determination of duloxetine in human plasma
【24h】

Dispersive liquid-liquid microextraction based on solidification of floating organic droplets followed by high performance liquid chromatography for the determination of duloxetine in human plasma

机译:基于漂浮有机液滴固化的分散液-液微萃取-高效液相色谱法测定人血浆中度洛西汀

获取原文
获取原文并翻译 | 示例
           

摘要

A novel dispersive liquid-liquid microextraction method based on solidification of floating organic droplets (DLLME-SFO) technique was developed for the determination of duloxetine in human plasma samples by high performance liquid chromatography with fluorescence detection (HPLC-FLD). During the extraction procedure, plasma protein was precipitated by using a mixture of zinc sulfate solution and acetonitrile. After the protein precipitation step, duloxetine in an alkaline sample solution was quickly extracted by DLLME-SFO with 50μL of 1-undecanol (extractant). Disperser was unnecessary because the small amount of remaining acetonitrile, which acts as a protein precipitating reagent, was also employed as a disperser; therefore, organic solvent consumption was reduced as much as possible. The emulsion was centrifuged and then fine droplets were floated to the top of the sample solution. The floated droplets were solidified in an ice bath and easily transferred. Various DLLME-SFO parameters such as extractant type, extractant amount, ionic strength, pH and extraction time were optimized. The chromatographic separation of duloxetine was carried out using ethanol as mobile phase. Validation of the method was performed with respect to linearity, intra- and inter-day accuracy and precision, limit of quantification (LOQ), and recovery. Calibration curves for duloxetine showed good linearity with correlation coefficients (r2) higher than 0.99. The method showed good precision and accuracy, with intra- and inter-assay coefficients of variation less than 15% (LOQ: less than 20%) at all concentrations. The recovery was carried out following the standard addition procedure with yields ranging from 59.6 to 65.5%. A newly developed environmentally friendly method was successfully applied to the pharmacokinetic study of duloxetine in human plasma and was shown to be an alternative green approach compared with the conventional solid-phase microextraction (SPME) and dispersive liquid-liquid microextraction (DLLME) techniques.
机译:建立了一种基于漂浮有机液滴固化的新型分散液-液微萃取技术(DLLME-SFO),用于高效液相色谱-荧光检测(HPLC-FLD)测定人血浆样品中的度洛西汀。在提取过程中,使用硫酸锌溶液和乙腈的混合物沉淀血浆蛋白。蛋白质沉淀步骤后,碱性样品溶液中的度洛西汀通过DLLME-SFO与50μL的1-十一烷醇(萃取剂)快速萃取。分散剂是不必要的,因为还使用了少量残留的乙腈(它是蛋白质沉淀剂)作为分散剂。因此,尽可能减少了有机溶剂的消耗。将乳液离心,然后将细小液滴漂浮到样品溶液的顶部。漂浮的液滴在冰浴中固化并易于转移。优化了各种DLLME-SFO参数,如萃取剂类型,萃取剂量,离子强度,pH和萃取时间。使用乙醇作为流动相进行度洛西汀的色谱分离。关于线性,日间和日间准确性和精密度,定量限(LOQ)和回收率,对该方法进行了验证。度洛西汀的校准曲线显示出良好的线性,相关系数(r2)高于0.99。该方法显示出良好的精密度和准确性,在所有浓度下,测定内和测定间变异系数均小于15%(LOQ:小于20%)。按照标准添加程序进行回收,产率为59.6至65.5%。一种新开发的环保方法已成功地应用于度洛西汀在人血浆中的药代动力学研究,与常规固相微萃取(SPME)和分散液-液微萃取(DLLME)技术相比,它被证明是一种替代的绿色方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号